|
|
Volumn 33, Issue 35, 2014, Pages 4385-4395
|
|
Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression
a a a a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
CISPLATIN;
DASATINIB;
PAXILLIN;
PYRIMIDINE DERIVATIVE;
SELUMETINIB;
THIAZOLE DERIVATIVE;
ANIMAL;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG EFFECTS;
DRUG RESISTANCE;
DRUG SCREENING;
FEMALE;
GENE EXPRESSION REGULATION;
HUMAN;
LUNG NEOPLASMS;
MALE;
METABOLISM;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BENZIMIDAZOLES;
CARCINOMA, NON-SMALL-CELL LUNG;
CELL LINE, TUMOR;
CISPLATIN;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LUNG NEOPLASMS;
MALE;
MAP KINASE SIGNALING SYSTEM;
MICE;
MICE, NUDE;
PAXILLIN;
PHOSPHORYLATION;
PYRIMIDINES;
THIAZOLES;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
|
EID: 85028215012
PISSN: None
EISSN: 14765594
Source Type: Journal
DOI: 10.1038/onc.2013.389 Document Type: Article |
|
Times cited : (62)
|
|
References (0)
|